Bank of America
BEAM icon

Bank of America’s Beam Therapeutics BEAM Stock Holding History

Bank of America’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8M Buy
538,290
+110,962
+26% +$3.08M ﹤0.01% 2763
2025
Q4 		$11.8M Sell
427,328
-351,696
-45% -$8.97M ﹤0.01% 2724
2025
Q3 		$18.9M Sell
779,024
-72,312
-8% -$1.44M ﹤0.01% 2671
2025
Q2 		$14.5M Buy
851,336
+177,556
+26% +$3.09M ﹤0.01% 2866
2025
Q1 		$13.2M Buy
673,780
+536,847
+392% +$14.1M ﹤0.01% 2865
2024
Q4 		$3.4M Sell
136,933
-403,054
-75% -$10.3M ﹤0.01% 3969
2024
Q3 		$13.2M Buy
539,987
+177,850
+49% +$4.59M ﹤0.01% 2800
2024
Q2 		$8.48M Buy
362,137
+41,085
+13% +$1.01M ﹤0.01% 3104
2024
Q1 		$10.6M Buy
321,052
+126,724
+65% +$3.95M ﹤0.01% 2933
2023
Q4 		$5.29M Sell
194,328
-172,389
-47% -$4.28M ﹤0.01% 3502
2023
Q3 		$8.82M Buy
366,717
+188,431
+106% +$5.05M ﹤0.01% 2837
2023
Q2 		$5.69M Sell
178,286
-199,334
-53% -$6.47M ﹤0.01% 3272
2023
Q1 		$11.6M Buy
377,620
+213,502
+130% +$8.43M ﹤0.01% 2679
2022
Q4 		$6.42M Buy
164,118
+44,343
+37% +$1.99M ﹤0.01% 3153
2022
Q3 		$5.71M Sell
119,775
-18,485
-13% -$1.05M ﹤0.01% 3205
2022
Q2 		$5.35M Buy
138,260
+547
+0.4% +$21.7K ﹤0.01% 3324
2022
Q1 		$7.89M Buy
137,713
+28,450
+26% +$1.87M ﹤0.01% 3101
2021
Q4 		$8.71M Buy
109,263
+91,841
+527% +$7.86M ﹤0.01% 3073
2021
Q3 		$1.51M Buy
17,422
+2,087
+14% +$210K ﹤0.01% 4689
2021
Q2 		$1.97M Sell
15,335
-4,605
-23% -$367K ﹤0.01% 4328
2021
Q1 		$1.6M Buy
19,940
+10,838
+119% +$1.03M ﹤0.01% 4450
2020
Q4 		$743K Buy
9,102
+4,590
+102% +$226K ﹤0.01% 4727
2020
Q3 		$111K Sell
4,512
-4,164
-48% -$103K ﹤0.01% 5638
2020
Q2 		$243K Buy
8,676
+2,154
+33% +$46.4K ﹤0.01% 5103
2020
Q1 		$117K Buy
+6,522
New +$142K ﹤0.01% 5419

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank of America's BEAM Position: Q1 2026 in Review

Bank of America increased its Beam Therapeutics (BEAM) stake by 26% in Q1 2026, buying an estimated $3.08M and bringing the position to 538,290 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2763.

Bank of America first reported a position in BEAM in Q1 2020 and has held it in 25 quarters since. The position peaked at $18.9M in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Bank of America held 538,290 shares of Beam Therapeutics worth $12.8M as of Q1 2026.
  • Bank of America bought 110,962 Beam Therapeutics shares in Q1 2026, an estimated $3.08M.
  • Beam Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2763 holding.
  • Bank of America first reported a position in Beam Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Bank of America's Beam Therapeutics position peaked at $18.9M in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.